Poor prognostic factors for Gangrene of the External Genital Organs over the last decade in West Africa: case of Ivory Coast

Main Article Content

A Fofana
I Coulibaly
N Coulibaly
EK Yao
A Drabo
DKMA Konan
GAP Gnabro

Abstract

Introduction: External genitalia gangrene (EGG) is a rare pathology today whose mortality rate remains high in sub- Saharan Africa.


Objective: To report poor prognostic factors in patients treated for EGG.


Patients and Methods: This was a descriptive and analytical cross-sectional study of the files of patients treated for EGG between 2013 and 2022 at the urology department of the CHU of Cocody-Abidjan. The measured variables were obtained from data from the hospitalisation and consultation files of these patients. It aimed to identify risk factors for unfavorable outcomes.


Results: The series included 73 male patients whose mean age was 49 years with borderline of 16 to 108 years. The mortality rate was 10.96%. The post-therapeutic follow-up concerned 65 patients alive for 5 months to 10 years after the initial management and the general quality of life overall was preserved. There were more deaths in patients treated within a period greater than or equal to 3 days. Diabetic patients had a hospital stay of up to 30 days. Diabetes and delay in treatment were the main negative factors (X2 = 17,73 and p = 0069 < 0,05 significative).


Conclusion: Patients treated for EGG presented a severe alteration of their quality of life before treatment. A multidisciplinary care pathway in emergency, screening for fragility factors could improve the functional and vital prognosis of these patients.

Article Details

Section
Original Research
Author Biographies

A Fofana, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire

I Coulibaly, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire

N Coulibaly, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire

EK Yao, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire

A Drabo, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire

DKMA Konan, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire

GAP Gnabro, Université Felix Houphouët Boigny

Université Felix Houphouët Boigny, UFR Sciences Médicales, Département de Chirurgie et Spécialités Shirurgicales, Service d’urologie Andrologie CHU, Cocody Abidjan, Cote d’Ivoire